EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    2.7.1.82 | Cardiomyopathies |
21494094 |
Phospholipid homeostasis and lipotoxic cardiomyopathy: A matter of balance. |
causal interaction
unassigned |
3
0 |
| 2.7.1.82 | Eosinophilia |
25615281 |
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
1
1
0 |
| 2.7.1.82 | Epilepsy |
20379606 |
Structural mass spectrometry analysis of lipid changes in a Drosophila epilepsy model brain. |
therapeutic application
unassigned |
1
0 |
| 2.7.1.82 | Fatty Liver |
33615637 |
Complement C3 participates in the development of goose fatty liver potentially by regulating the expression of FASN and ETNK1. |
unassigned |
0 |
| 2.7.1.82 | Fetal Death |
16861741 |
Placental thrombosis and spontaneous fetal death in mice deficient in ethanolamine kinase 2. |
causal interaction
ongoing research
unassigned |
3
3
0 |
| 2.7.1.82 | Infections |
25046486 |
Kinome siRNA screen identifies novel cell-type specific dengue host target genes. |
diagnostic usage
unassigned |
1
0 |
| 2.7.1.82 | Laryngeal Neoplasms |
25719218 |
Radioresistance in a human laryngeal squamous cell carcinoma cell line is associated with DNA methylation changes and topoisomerase II alpha. |
ongoing research
unassigned |
3
0 |
| 2.7.1.82 | Leukemia |
25343957 |
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 2.7.1.82 | Leukemia |
25615281 |
Novel recurrent mutations in ethanolamine kinase 1 (ETNK1) gene in systemic mastocytosis with eosinophilia and chronic myelomonocytic leukemia. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
3
1
1
0 |
| 2.7.1.82 | Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative |
25343957 |
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
